Niramai gets US FDA clearance for their first medical device, SMILE-100 System
US markets now open for the Innovative Indian Startup Bengaluru,…
Breast cancer is the leading cause of cancer deaths in women today. According to the World Health Organization (WHO), one in every 12 women have the risk of a breast abnormality. Early diagnosis is very critical to decrease mortality rates. We, at NIRAMAI, have developed a novel software-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination. Our solution is a low cost, accurate, automated, portable cancer screening tool that can be operated in any clinic. Our imaging method is radiation free, non-touch, not painful and works for women of all ages. The core technology of our solution has been developed using our patented machine learning algorithms for reliable and accurate detection of breast cancer. This unique solution can be used as a cancer diagnosis test in hospitals, for regular preventive health checkups, and also for large scale screening in rural and semi-urban areas. Niramai Thermalytix is available in 30 cities in India across 150+ Hospitals and Diagnostic Centers. Our customers include Apollo Clinics, HCG, Narayana Health, Rainbow Hospitals among others. Niramai test is also available in United Arab Emirates, Kenya, Sweden, Turkey, and Philippines through our distributors.
Radiation-free. Does not require any incision.
No one touches or even sees you
Best in class sensitivity & specificity.
Niramai has multiple products for Breast Screening.
NIRAMAI breast cancer screening test, Thermalytix, is a computer aided diagnostic engine that is powered by Artificial Intelligence. The solution uses a high resolution thermal sensing device and a cloud hosted analytics solution for analysing the thermal…
Read MoreThe SMILE-100 System is US FDA cleared test that helps a healthcare personnel to review, measure and analyze thermally significant indications in the breast region. It can be used in the hospital, acute care settings, outpatient surgery,…
Read MoreMythri Thermalytix is a low-cost device for breast cancer triaging and risk assessment that can be used for screening in primary health care centers. This product is available only in India.
Read MoreMore than 800+ articles about Niramai Health Analytix
US markets now open for the Innovative Indian Startup Bengaluru,…
Niramai among winners of The Global Women’s HealthTech Awards announced…
Bengaluru-based healthtech startup Niramai Health Analytix’s patented, radiation-free breast cancer…
Niramai won the PHC Tech Challenge award conducted by PATH, CCAMP, et al
Selected for Marico Innovation Foundation Scale-Up program and tagged as Pride of India
Niramai was awarded Aegis Graham Bell Award 2018 under Innovative Mobile App for Consumer
Niramai is among 4 startups from India that got selected for Google Launchpad Accelerator Program 2018